Magnetic resonance spectroscopy in patients with insomnia: A repeated measurement study

PLoS ONE

Volumn 11, Issue 6, 2016, Pages

  Spiegelhalder, Kai ^a,b   Regen, Wolfram ^a   Nissen, Christoph ^a   Feige, Bernd ^a   Baglioni, Chiara ^a   Riemann, Dieter ^a   Hennig, Jürgen ^a   Lange, Thomas ^a,b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; GLUTAMIC ACID; GLUTAMINE;

4 AMINOBUTYRIC ACID BRAIN LEVEL; ADULT; AGE; ANTERIOR CINGULATE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DORSOLATERAL PREFRONTAL CORTEX; FEMALE; HUMAN; INSOMNIA; MALE; MIDDLE AGED; MIXED INSOMNIA; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; REPEAT PROCEDURE; SLEEP MAINTENANCE INSOMNIA; SLEEP ONSET INSOMNIA; SLEEP QUALITY; SLEEP TIME; VOXEL BASED MORPHOMETRY; BRAIN; BRAIN CHEMISTRY; CASE CONTROL STUDY; DIAGNOSTIC IMAGING; METABOLISM; POLYSOMNOGRAPHY; PROCEDURES; SLEEP INITIATION AND MAINTENANCE DISORDERS;

ADULT; BRAIN; BRAIN CHEMISTRY; CASE-CONTROL STUDIES; FEMALE; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; GLUTAMINE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 84976276922     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0156771     Document Type: Article

References (64)

1. Morin CM, Drake C, Harvey AG, Krystal AD, Manber R, Riemann D, et al. Insomnia Disorder. Nat Rev Dis Primers. In press.
2. Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev. 2002; 6: 97-111. PMID: 12531146
3. Kyle SD, Morgan K, Espie CA. Insomnia and health-related quality of life. Sleep Med Rev. 2010; 14: 69-82. doi: 10.1016/j.smrv.2009.07.004 PMID: 19962922
4. Fortier-Brochu E, Beaulieu-Bonneau S, Ivers H, Morin CM. Insomnia and daytime cognitive performance: a meta-analysis. Sleep Med Rev. 2012; 16: 83-94. doi: 10.1016/j.smrv.2011.03.008 PMID: 21636297
5. Baglioni C, Battagliese G, Feige B, Spiegelhalder K, Nissen C, Voderholzer U, et al. Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies. J Affect Disord. 2011; 135: 10-19. doi: 10.1016/j.jad.2011.01.011 PMID: 21300408
6. Spiegelhalder K, Regen W, Nanovska S, Baglioni C, Riemann D. Comorbid sleep disorders in neuropsychiatric disorders across the life cycle. Curr Psychiatry Rep. 2013; 15: 364. doi: 10.1007/s11920-013-0364-5 PMID: 23636987
7. Johann A, Baglioni C, Hertenstein E, Riemann D, Spiegelhalder K. Prevention of mental disorders through cognitive behavioral therapy for insomnia. Somnologie. 2015; 19: 88-92.
8. Sofi F, Cesari F, Casini A, Macchi C, Abbate R, Gensini GF. Insomnia and risk of cardiovascular disease: a meta-analysis. Eur J Prev Cardiol. 2014; 21: 57-64. doi: 10.1177/2047487312460020 PMID: 22942213
9. Laugsand LE, Vatten LJ, Platou C, Janszky I. Insomnia and the risk of acute myocardial infarction: a population study. Circulation. 2011; 124: 2073-2081. doi: 10.1161/CIRCULATIONAHA.111.025858PMID: 22025601
10. Laugsand LE, Strand LB, Platou C, Vatten LJ, Janszky I. Insomnia and the risk of incident heart failure: a population study. Eur Heart J. 2014; 35: 1382-1393. doi: 10.1093/eurheartj/eht019 PMID: 23462728
11. Spiegelhalder K, Johann A, Hertenstein E, Baglioni C, Riemann D. Die Prävention körperlicher Erkrankungen durch eine Behandlung von Insomnien [The prevention of somatic disorders through insomnia treatment]. Somnologie. 2015; 19: 93-97.
12. Kucharczyk ER, Morgan K, Hall AP. The occupational impact of sleep quality and insomnia symptoms. Sleep Med Rev. 2012; 16: 547-559. doi: 10.1016/j.smrv.2012.01.005 PMID: 22401983
13. Shahly V, Berglund PA, Coulouvrat C, Fitzgerald T, Hajak G, Roth T, et al. The associations of insomnia with costly workplace accidents and errors: results from the America Insomnia Survey. Arch Gen Psychiatry. 2012; 69: 1054-1063. doi: 10.1001/archgenpsychiatry.2011.2188 PMID: 23026955
14. Léger D, Bayon V. Societal costs of insomnia. Sleep Med Rev. 2010; 14: 379-389. doi: 10.1016/j.smrv. 2010.01.003 PMID: 20359916
15. Riemann D, Nissen C, Palagini L, Otte A, Perlis ML, Spiegelhalder K. The neurobiology, investigation, and treatment of chronic insomnia. Lancet Neurol. 2015; 14: 547-558. doi: 10.1016/S1474-4422(15) 00021-6 PMID: 25895933
16. Saper CB, Scammell TE, Lu J. Hypothalamic regulation of sleep and circadian rhythms. Nature. 2005; 437: 1257-1263. PMID: 16251950
17. Bertisch SM, Herzig SJ, Winkelman JW, Buettner C. National use of prescription medications for insomnia: NHANES 1999-2010. Sleep. 2014; 37: 343-349. doi: 10.5665/sleep.3410 PMID: 24497662
18. Huedo-Medina TB, Kirsch I, Middlemass J, Klonizakis M, Siriwardena AN. Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the Food and Drug Administration. BMJ. 2012; 345: e8343. doi: 10.1136/bmj.e8343 PMID: 23248080
19. Glass J, Lanctot KL, Herrmann N, Sproule BA, Busto UE. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ. 2005; 331: 1169. PMID: 16284208
20. Winkelman JW, Buxton OM, Jensen JE, Benson KL, O'Connor SP, Wang W, et al. Reduced brain GABA in primary insomnia: preliminary data from 4T proton magnetic resonance spectroscopy (1H-MRS). Sleep. 2008; 31: 1499-1506. PMID: 19014069
21. Plante DT, Jensen JE, Schoerning L, Winkelman JW. Reduced γ-aminobutyric acid in occipital and anterior cingulate cortices in primary insomnia: a link to major depressive disorder? Neuropsychopharmacology. 2012; 37: 1548-1557. doi: 10.1038/npp.2012.4 PMID: 22318195
22. Riemann D, Spiegelhalder K, Feige B, Voderholzer U, Berger M, Perlis M, et al. The hyperarousal model of insomnia: a review of the concept and its evidence. Sleep Med Rev. 2010; 14: 19-31. doi: 10. 1016/j.smrv.2009.04.002 PMID: 19481481
23. Morgan PT, Pace-Schott EF, Mason GF, Forselius E, Fasula M, Valentine GW, et al. Cortical GABA levels in primary insomnia. Sleep. 2012; 35: 807-814. doi: 10.5665/sleep.1880 PMID: 22654200
24. Plante DT, Jensen JE, Winkelman JW. The role of GABA in primary insomnia. Sleep. 2012; 35: 741-742. doi: 10.5665/sleep.1854 PMID: 22654187
25. Mescher M, Merkle H, Kirsch J, Garwood M, Gruetter R. Simultaneous in vivo spectral edifting and water suppression. NMR Biomed. 1998; 11: 266-272. PMID: 9802468
26. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR Fourth Edition (Text Revision). 4th ed. Washington, DC: American Psychiatric Publishing; 2000.
27. Regen W, Kyle SD, Nissen C, Feige B, Baglioni C, Hennig J, et al. Objective sleep disturbances are associated with greater waking resting-state connectivity between the retrosplenial cortex/ hippocampus and various nodes of the default mode network. J Psychiatry Neurosci. In press.
28. Baglioni C, Spiegelhalder K, Regen W, Feige B, Nissen C, Lombardo C, et al. Insomnia disorder is associated with increased amygdala reactivity to insomnia-related stimuli. Sleep. 2014; 37: 1907-1917. doi: 10.5665/sleep.4240 PMID: 25325493
29. Reinhard MA, Regen W, Baglioni C, Nissen C, Feige B, Hennig J, et al. The relationship between brain morphology and polysomnography in healthy good sleepers. PLoS One. 2014; 9: e109336. doi: 10. 1371/journal.pone.0109336 PMID: 25275322
30. Spiegelhalder K, Regen W, Baglioni C, Klöppel S, Abdulkadir A, Hennig J, et al. Insomnia Does Not Appear to be Associated With Substantial Structural Brain Changes. Sleep. 2013; 36: 731-737. doi: 10.5665/sleep.2638 PMID: 23633756
31. Spiegelhalder K, Regen W, Prem M, Baglioni C, Nissen C, Feige B, et al. Reduced internal capsule white matter integrity in primary insomnia. Hum Brain Mapp. 2014; 35: 3431-3438. PMID: 25050429
32. American Academy of Sleep Medicine. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications. Westchester: AASM; 2007.
33. Bastien CH, Vallières A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2001; 2: 297-307. PMID: 11438246
34. Buysse DJ, Reynolds CF III, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: A New Instrument for Psychiatric Practice and Research. Psychiatry Res. 1989; 28: 193-213. PMID: 2748771
35. Morin CM, Vallières A, Ivers H. Dysfunctional beliefs and attitudes about sleep (DBAS): validation of a brief version (DBAS-16). Sleep. 2007; 30: 1547-1554. PMID: 18041487
36. Broomfield NM, Espie CA. Towards a valid, reliable measure of sleep effort. J Sleep Res. 2005; 14: 401-407. PMID: 16364141
37. Nicassio PM, Mendlowitz DR, Fussell JJ, Petras L. The phenomenology of the pre-sleep state: the development of the pre-sleep arousal scale. Behav Res Ther. 1985; 23: 263-271. PMID: 4004706
38. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991; 14: 540-545. PMID: 1798888
39. Horne JA, Östberg O. A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. Int J Chronobiol. 1976; 4: 97-110. PMID: 1027738
40. Beck AT, Steer RA. Beck Depression Inventory. San Antonio: The Psychological Corporation; 1987.
41. Spielberger CD, Gorsuch RL, Lushene R, Vogg PR, Jacobs GA. Manual for the state-trait anxiety inventory. Palo Alto: Consulting Psychologists Press; 1983.
42. Mugler Brookeman JR. Three-dimensional magnetization-prepared rapid gradient-echo imaging (3D MP RAGE). Magn Reson Med. 1990; 15: 152-157. PMID: 2374495
43. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med. 1993; 30: 672-679. PMID: 8139448
44. Provencher SW. Automatic quantification of localized in vivo 1H spectra with LCModel. NMR Biomed. 2001; 14: 260-264. PMID: 11410943
45. Cavassila S, Deval S, Huegen C, van Ormondt D, Graveron-Demilly D. Cramér-Rao bounds: an evaluation tool for quantitation. NMR Biomed. 2001; 14: 278-283. PMID: 11410946
46. Bogner W, Gruber S, Doelken M, Stadlbauer A, Ganslandt O, Boettcher U, et al. In vivo quantification of intracerebral GABA by single-voxel (1)H-MRS-How reproducible are the results? Eur J Radiol. 2010; 73: 526-531. doi: 10.1016/j.ejrad.2009.01.014 PMID: 19201120
47. Mlynárik V, Gruber S, Moser E. Proton T (1) and T (2) relaxation times of human brain metabolites at 3Tesla. NMR Biomed. 2001; 14: 325-331. PMID: 11477653
48. Edden RA, Intrapiromkul J, Zhu H, Cheng Y, Barker PB. Measuring T2 in vivo with J-difference editing: application to GABA at 3 Tesla. J Magn Reson Imaging. 2012; 35: 229-234. doi: 10.1002/jmri.22865PMID: 22045601
49. Ganji SK, Banerjee A, Patel AM, Zhao YD, Dimitrov IE, Browning JD, et al. T2 measurement of J-coupled metabolites in the human brain at 3T. NMR Biomed. 2012; 25: 523-529. doi: 10.1002/nbm.1767PMID: 21845738
50. Puts NA, Barker PB, Edden RA. Measuring the longitudinal relaxation time of GABA in vivo at 3 Tesla. J Magn Reson Imaging. 2013; 37: 999-1003. doi: 10.1002/jmri.23817 PMID: 23001644
51. Bhattacharyya PK. Macromolecules contamination in GABA editing using MEGA-PRESS should be properly accounted for. Neuroimage. 2014; 84: 1111-1112. doi: 10.1016/j.neuroimage.2013.08.050PMID: 24004693
52. Long Z, Dyke JP, Ma R, Huang CC, Louis ED, Dydak U. Reproducibility and effect of tissue composition on cerebellar γ-aminobutyric acid (GABA) MRS in an elderly population. NMR Biomed. 2015; 28: 1315-1323. doi: 10.1002/nbm.3381 PMID: 26314380
53. Near J, Ho YC, Sandberg K, Kumaragamage C, Blicher JU. Long-term reproducibility of GABA magnetic resonance spectroscopy. Neuroimage. 2014; 99: 191-196. doi: 10.1016/j.neuroimage.2014.05.059 PMID: 24875142
54. Evans CJ, McGonigle DJ, Edden RA. Diurnal stability of gamma-aminobutyric acid concentration in visual and sensorimotor cortex. J Magn Reson Imaging. 2010; 31: 204-209. doi: 10.1002/jmri.21996PMID: 20027589
55. Spiegelhalder K, Regen W, Baglioni C, Nissen C, Riemann D, Kyle SD. Neuroimaging insights into insomnia. Curr Neurol Neurosci Rep. 2015; 15: 9. doi: 10.1007/s11910-015-0527-3 PMID: 25687698
56. Button KS, Ioannidis JP, Mokrysz C, Bosek BA, Flint J, Robinson ES, et al. Power failure: why small sample size undermines the reliability of neuroscience. Nat Rev Neurosci. 2013; 14: 365-376. doi: 10. 1038/nrn3475 PMID: 23571845
57. Ioannidis JP. Why most discovered true associations are inflated. Epidemiology. 2008; 19: 640-648. doi: 10.1097/EDE.0b013e31818131e7 PMID: 18633328
58. Vgontzas AN, Fernandez-Mendoza J, Liao D, Bixler EO. Insomnia with objective short sleep duration: the most biologically severe phenotype of the disorder. Sleep Med Rev. 2013; 17: 241-254. doi: 10. 1016/j.smrv.2012.09.005 PMID: 23419741
59. Lanfranchi PA, Pennestri MH, Fradette L, Dumont M, Morin CM, Montplaisir J. Nighttime blood pressure in normotensive subjects with chronic insomnia: implications for cardiovascular risk. Sleep. 2009; 32: 760-766. PMID: 19544752
60. Spiegelhalder K, Fuchs L, Ladwig J, Kyle SD, Nissen C, Voderholzer U, et al. Heart rate and heart rate variability in subjectively reported insomnia. J Sleep Res. 2011; 20: 137-145. doi: 10.1111/j.1365-2869.2010.00863.x PMID: 20626615
61. Meyerhoff DJ, Mon A, Metzler T, Neylan TC. Cortical gamma-aminobutyric acid and glutamate in posttraumatic stress disorder and their relationships to self-reported sleep quality. Sleep. 2014; 37: 893-900. doi: 10.5665/sleep.3654 PMID: 24790267
62. Near J, Andersson J, Maron E, Mekle R, Gruetter R, Cowen P, et al. Unedited in vivo detection and quantification of γ-aminobutyric acid in the occipital cortex using short-TE MRS at 3 T. NMR Biomed. 2013; 26: 1353-1362. doi: 10.1002/nbm.2960 PMID: 23696182
63. Near J, Simpson R, Cowen P, Jezzard P. Efficient γ-aminobutyric acid editing at 3T without macromolecule contamination: MEGA-SPECIAL. NMR Biomed. 2011; 24: 1277-1285. doi: 10.1002/nbm.1688PMID: 21387450
64. De Bondt R, De Belder F, Vanhevel F, Jacquemyn Y, Parizel PM. Prefrontal GABA concentration changes in women-influence of menstrual cycle phase, hormonal contraceptive use, and correlation with premenstrual symptoms. Brain Res. 2015; 1597: 129-138. doi: 10.1016/j.brainres.2014.11.051PMID: 25481417